Eli Lilly v. Empower Clinic Services — Court Dismisses Lanham Act Claim Against Compounding Pharmacy but Allows State Consumer Protection Claims to Proceed
A federal court dismissed Eli Lilly’s Lanham Act false advertising claim against Empower Pharmacy over compounded tirzepatide (the active ingredient in Mounjaro and Zepbound) for lack of proximate causation, but allowed state consumer protection claims to proceed in eight states.